SEC Form D private-offering filing
BiomX Inc.
A new SEC Form D private-offering notice from Ness Ziona, a $3,300,000 filer-stated offering target in Biotech. The source filing is one click away.
Clinical stage biotechnology company developing natural and engineered phage therapies to target harmful bacteria in chronic diseases such as cystic fibrosis and diabetic foot infections.
Filed 2026-01-20Filed to raise $3,300,000First money in 2026-01-13Raised so far $3,300,000HQ (as filed) Ness ZionaSector Biotech ✓Stage (inferred) SeedCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified biomx.com↗Named in the filing 10 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.